Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JNCE | ZTS | TAK | NBIX | UTHR |
| Company | Jounce Therapeutics Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.9200 | 165.50 | 13.30 | 140.18 | 255.10 |
| High | 1.9300 | 165.50 | 13.30 | 145.22 | 255.10 |
| Low | 1.8800 | 165.50 | 13.30 | 136.01 | 255.10 |
| Last | 1.8800 | 165.50 | 13.30 | 143.03 | 255.10 |
| Change | -0.0500 | +7.00 | +0.11 | +5.49 | -0.04 |
| % Change | -2.59% | +4.42% | +0.83% | +3.99% | -0.02% |
| Volume | 11,600,600 | 10,073 | 459 | 1,601,900 | 271 |
| 20-Day Average Volume | 1,541,820 | 4,341,374 | 1,598,023 | 802,105 | 505,284 |
| Previous Close | 1.9300 | 158.50 | 13.19 | 137.54 | 255.14 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.9078 | 156.48 | 13.31 | 136.60 | 237.52 |
| 20-Day Raw Stochastic | 16.67% | 84.18% | 38.31% | 85.49% | 87.97% |
| 20-Day Relative Strength | 62.73% | 51.57% | 42.14% | 58.55% | 64.40% |
| Weighted Alpha | -65.90 | -12.58 | -20.72 | +48.43 | +21.91 |
| Today's Opinion | 24% Buy | 64% Sell | 100% Sell | 88% Buy | 88% Buy |
| Previous Opinion | 40% Buy | 72% Sell | 100% Sell | 80% Buy | 88% Buy |
| Last Month's Opinion | 24% Buy | 56% Sell | 80% Sell | 88% Buy | 16% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.59% since 04/26/23 | +7.92% since 04/25/24 | +1.76% since 04/25/24 | +2.92% since 04/24/24 | +8.12% since 04/25/24 |
| Low | 1.8800 on 05/03/23 | 152.63 on 04/26/24 | 13.01 on 04/26/24 | 135.17 on 04/26/24 | 233.31 on 04/30/24 |
| High | 1.9500 on 04/28/23 | 165.50 on 05/02/24 | 13.30 on 05/02/24 | 145.22 on 05/01/24 | 258.48 on 05/01/24 |
| 1-Month | |||||
| %Chg | +1.62% since 04/03/23 | +0.30% since 04/02/24 | -1.85% since 04/02/24 | +1.17% since 04/01/24 | +11.60% since 04/02/24 |
| Low | 1.8400 on 04/04/23 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 130.13 on 04/19/24 | 227.75 on 04/03/24 |
| High | 1.9800 on 04/17/23 | 169.39 on 04/05/24 | 13.77 on 04/08/24 | 145.22 on 05/01/24 | 258.48 on 05/01/24 |
| 3-Month | |||||
| %Chg | +55.37% since 02/03/23 | -12.45% since 02/02/24 | -6.86% since 02/02/24 | +0.41% since 02/01/24 | +19.54% since 02/02/24 |
| Low | 0.8957 on 03/10/23 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 128.00 on 02/07/24 | 208.62 on 02/08/24 |
| High | 1.9800 on 04/17/23 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | 258.48 on 05/01/24 |
| 6-Month | |||||
| %Chg | -10.48% since 11/03/22 | +2.85% since 11/02/23 | -4.11% since 11/02/23 | +28.23% since 11/01/23 | +11.80% since 11/02/23 |
| Low | 0.5773 on 12/13/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 103.63 on 11/10/23 | 208.62 on 02/08/24 |
| High | 2.1180 on 11/09/22 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | 258.48 on 05/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 98,954 | 72,491,408 | 41,744,196 | 14,232,486 | 11,319,541 |
| Shares Outstanding, K | 52,635 | 457,359 | 3,164,837 | 99,507 | 44,366 |
| Annual Sales | 82,000,000 | 8,544,000,000 | 29,803,340,000 | 1,887,100,000 | 2,327,500,000 |
| Annual Net Income | -50,920,000 | 2,344,000,000 | 2,345,930,000 | 249,700,000 | 984,800,000 |
| Last Quarter Sales | 82,000,000 | 2,213,000,000 | 7,556,070,000 | 515,200,000 | 614,700,000 |
| Last Quarter Net Income | 50,960,000 | 525,000,000 | 718,900,000 | 147,700,000 | 217,100,000 |
| 60-Month Beta | 0.75 | 0.86 | 0.56 | 0.28 | 0.54 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.60 on 11/10/22 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 1.20 on 05/01/24 | 6.17 on 05/01/24 |
| Latest Earnings Date | 05/04/23 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 29.93 | 6.71 | 56.83 | 11.81 |